• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Time will define Juvederm's place among HA fillers

Article

National report - Many in dermatology are anxiously anticipating the arrival of the latest addition to the hyaluronic acid filler market, Juvederm (Allergan Medical), as a new alternative to the long-held gold standard, Restylane (Medicis ?sthetics).

Related Videos
© 2024 MJH Life Sciences

All rights reserved.